Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Kudingxiang Tongqi Suppository after abdominal gastrointestinal surgery
ChiCTR-TRC-13004069Phase 3Completed
- Sponsor
- Peking University People's Hospital
- Start
- Sep 2012
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of kudingxiang tongqi in postoperative ileus (POI) (2 arms), sponsored by Peking University People's Hospital. Primary endpoints: Time to first passing flatus and Time to first passage of stool. Started Sep 2012; status: completed.
02
Drugs
kudingxiang tongqi
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on ChiCTR-TRC-13004069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13004069.